Newspaper Publication of results for q.e. June 30,2025
KPL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kwality Pharmaceuticals Ltd has submitted a compliance notice to BSE confirming that its unaudited financial results (standalone and consolidated) for Q1 FY26 (quarter ended June 30, 2025) were published in the Financial Express (English) and Punjabi Jagran (Punjabi) newspapers on August 13, 2025, as mandated under SEBI LODR Regulation 47. The company highlighted that the Audit Committee reviewed the results on August 11, 2025, and the Board approved them on the same date. From the published extract, standalone total income from operations stood at Rs. 11,147.90 lakhs versus Rs. 8,002.88 lakhs in Q1 FY25, showing ~39% YoY revenue growth. However, standalone net profit after tax fell sharply to Rs. 191.87 lakhs from Rs. 834.64 lakhs YoY, with consolidated net profit after tax at Rs. 193.22 lakhs (vs Rs. 836.68 lakhs YoY). The filing is signed by Whole Time Director & CFO Aditya Arora.
This is essentially a routine post-results regulatory disclosure, so the stock impact is minimal as the numbers were already filed with the exchanges earlier. However, the steep YoY drop in net profit despite strong revenue growth could draw investor attention and warrants a closer look at cost lines and margins.